Emmvee makes its own solar cells in a country that is short of them, which is why it earns a fat made-in-India premium and a 34% margin that the market values cheaply at about 17 times earnings. The catch is that the premium looks like a policy-and-shortage window rather than a permanent edge, and everyone in the industry is racing to build the cells that will close it.
Emmvee Photovoltaic Power makes solar panels (modules) and the solar cells that go inside them, at five plants clustered near Bengaluru. It is one of the few Indian makers that produces its own cells rather than importing them, which lets its panels qualify for government solar tenders that require domestic content.
Sector
Industrials · Solar Manufacturing
Founded
2007
Head office
Bengaluru
Revenue (FY26)
₹5,050 cr
Market cap
₹22,515 cr
Promoter holding
80.03%
Fathom view
Business
Integrated solar cell + module maker
Returns
51% ROE, 45% ROCE
Balance sheet
Near debt-free after IPO, D/E 0.10
Margin
~34%, at a policy-driven peak
Cash
FY26 cash conversion just 23%
Valuation
~17x earnings, cheapest of the integrated makers
Key questionThe one thing that decides it: how much of today's 34% margin survives once India's cell shortage ends? The premium that makes Emmvee this profitable comes from being one of few domestic cell makers, and the whole industry, Emmvee included, is building the cell capacity that erases that scarcity.
Emmvee earns a fat margin because it makes its own solar cells in a country short of them, and that margin is a shortage rent that the whole industry is spending to compete away.
India wants its solar power built at home, not imported from China, and it has written that preference into policy: a growing share of solar capacity must use Indian-made cells and modules to qualify for government support. That creates demand for domestic manufacturing that would not survive on cost alone, because Chinese panels are cheaper. Emmvee exists to fill the hardest part of that gap. It has made solar panels since 2007 and, more importantly, invested early in making its own cells, so it can supply the domestic-content market that pure assemblers cannot.
Why has no one else already won? Because cells are hard and India is short of them. Anyone with a shed and capital can assemble a solar panel from bought-in cells, which is why India has more than 200 GW of module capacity running at barely a third of capacity. Cells are different: they need a real fab, real process control, and years to ramp. Emmvee is one of a handful of Indian makers with meaningful cell capacity (2.94 GW) feeding its own panels, and from June 2026 the rules tighten further to require approved domestic cells, not just domestic panels. That is a genuine, if narrow, edge. But it is an edge everyone can see, so Premier, Waaree, Adani and Emmvee are all pouring money into cell fabs. The advantage is real today and shrinking by design.
The economic engine
Demand
India's domestic-content solar push
Government solar projects that must use Indian cells and modules. Structural in direction, but the premium it creates depends on scarcity.
Revenue
Cells and modules, sold by the watt
Paid per watt of panel shipped. Domestic-content (DCR) panels fetch far more per watt than ordinary ones, and were about half of recent revenue.
Margins
~34%, unusually high for panels
Panel-making is normally a thin-margin assembly job. The fat margin traces mostly to captive cells and a domestic-cell shortage, not to the panel itself, which stays a commodity.
Capital
Heavy and hungry
Cell and module fabs cost thousands of crore. Emmvee is spending ₹5,500 crore on a new 6 GW plant, so free cash flow is deeply negative during the build.
Returns
51% ROE, but low cash conversion
Returns on equity look spectacular, but FY26 turned only 23% of profit into operating cash as inventory and receivables ballooned.
Where the edge is (and isn’t)
Strong
Captive cell integration
Owning cell capacity in a cell-short market is the whole edge: it unlocks the high-priced domestic-content segment that assemblers cannot serve.
Mixed
Pricing power
Real today via the domestic-content premium, but it is a policy-and-scarcity rent, not a brand or switching-cost moat. Panels are ultimately a commodity.
Strong
Balance sheet
The IPO cut borrowings from about ₹2,065 crore to ₹360 crore, so leverage is low and interest cover comfortable going into a heavy capex cycle.
Weak
Cash conversion
FY26 operating cash was just 23% of profit as working capital swelled; free cash flow has been negative for three straight years.
High risk
Cyclicality
Both the domestic-cell premium and polysilicon-driven input costs swing the margin, and the industry is building the capacity that ends the shortage.
Mixed
Growth durability
Revenue and profit exploded off a small base and there is a booked order pipeline, but the margin behind that profit is the fragile part.
Strategic position
Waaree Energies, Premier Energies
Larger integrated makers with bigger cell and module capacity and deeper pockets for the fab race
↓
Emmvee
The second-largest pure-play integrated cell-and-module maker, cheaply valued, clustered and cost-focused near Bengaluru
↓
Module-only assemblers
A crowded tail that imports cells, cannot serve domestic-content tenders, and runs at low utilisation on thin margins
Why now
The setup, not any single event, is what makes now interesting. Emmvee is being valued on peak earnings by a market that is at the same time signalling it does not believe those margins last. Profit tripled in FY26, the November 2025 IPO raised about ₹2,144 crore that left the balance sheet clean, and the stock trades at roughly 17 times earnings against Premier Energies at over 30, yet it will not re-rate higher. Peak earnings, a cheap headline multiple, rapidly expanding capacity, and a cell shortage that is visibly starting to normalise. The low multiple is there because the earnings under it may be at their best.
What has to go right
India's domestic-content rules stay in force and keep creating a premium for Indian-made cells.
The cell shortage persists long enough for Emmvee's new 6 GW plant to earn a high return before the premium normalises.
Margins settle well above ordinary panel economics rather than reverting to them.
Working capital and cash conversion improve as the current expansion completes and the business matures.
Why the business works
Revenue up from ₹952 crore in FY24 to ₹5,050 crore in FY26, with extraordinary profit growth.
Operating margin near 34% and return on equity of about 51%, extraordinary for a panel maker.
A near debt-free balance sheet after the IPO cut borrowings from about ₹2,065 crore to ₹360 crore.
Captive cell capacity of 2.94 GW feeding 10.3 GW of fully TOPCon module capacity, with a booked order pipeline of 9.4 GW.
Why the thesis could fail
The 34% margin rests on a domestic-cell shortage and a policy premium that the whole industry is spending to compete away.
FY26 converted only 23% of profit to operating cash; free cash flow has been negative for three years as capex and working capital soak up money.
Silver-paste and polysilicon input costs are volatile and can swing the margin either way.
Chinese TOPCon panels sell far below Indian domestic-content prices, so the premium exists only as long as the rules and the shortage hold.
Sector mental models
Industry structure
Consolidating at the cell end
Module-making is fragmented and over-built; cell-making is concentrated in a few hands, and that is where the margin sits.
Pricing power
Policy-dependent
The domestic-content rules, not the market, create the premium. Change the rules or end the shortage and the pricing power fades.
Demand driver
Structural but rent-cyclical
India's solar build-out is a long runway, but the extraordinary margin rides a temporary domestic-cell shortage.
Cash conversion
Poor for now
Heavy capex plus a working-capital build have kept free cash flow negative through the growth phase.
Balance sheet
Clean post-IPO
D/E about 0.10 and interest cover above 11x after the fresh issue repaid debt.
One sentence to remember
Emmvee is not selling panels, it is selling the one thing India cannot yet make enough of: the cell inside the panel. The day India can, the premium goes.
01Company Overview
Emmvee makes solar panels and, unusually for India, the solar cells that go inside them. A solar panel is mostly an assembly job: buy the cells, wire them into a glass sandwich, and ship it. The cell is the hard, valuable part, and most Indian panel makers import theirs from China. Emmvee makes its own. That matters because India's government solar projects increasingly demand panels built from Indian cells, and there are not enough Indian cells to go around. So a maker that owns cell capacity can sell into the protected, higher-priced part of the market while rivals who only assemble panels fight over the cheap, commoditised part. This is why Emmvee's revenue went from about ₹950 crore to ₹5,050 crore in two years and its operating margin jumped to 34%, and why it earns 51% on equity. The stock, listed in late 2025, trades at a modest valuation for these returns. Emmvee's volume can keep growing for years while the economics of that volume quietly decay. The 9.4 GW order book is real; the margin on it is the fragile part. So the question is how much of that 34% margin is Emmvee's normal economics, and how much is the top of a shortage.
02Business Model & Industry
Unit of revenue: One watt of solar capacity shipped, as either a cell or a finished panel. A domestic-content (DCR) panel, one built from Indian cells for a government-backed project, has recently earned roughly ₹8.5 to ₹9 of gross profit per watt, against about ₹2 to ₹2.5 for an ordinary non-DCR panel. So the same physical product is worth three to four times more depending on which rulebook it is sold under, and that gap is the business.
Model: Manufacturing and selling cells and modules by the watt, on orders and supply contracts rather than long recurring subscriptions. About half of recent revenue was the high-priced domestic-content segment, unlocked by making its own cells; the rest is ordinary panels and merchant cell sales. Revenue therefore swings with both volume shipped and the mix between the protected and the commoditised segment.
Domestic-content (DCR) modules50%
The profit engine: panels built from Indian cells for tenders that mandate domestic content, earning roughly ₹8.5-9 per watt. High margin, but only because domestic cells are scarce.
Non-DCR modules and merchant cells50%
Ordinary panels and cell sales at roughly ₹2-2.5 per watt: the commoditised part of the market, priced against imported Chinese product.
Structure
Split in two. Module assembly is fragmented and heavily over-built (India has more than 200 GW of module capacity running near a third of it), while cell-making is concentrated in a few integrated hands. The margin lives at the concentrated end.
Competitors
Waaree Energies (the largest, about ₹26,500 crore of FY26 revenue) and Premier Energies (about ₹7,800 crore) are the bigger integrated makers; Adani Solar and Vikram Solar also compete. A long tail of assemblers imports cells and cannot serve domestic-content tenders.
Pricing power
Conditional. Strong inside the domestic-content segment while Indian cells are scarce, weak everywhere else, where Chinese TOPCon panels at roughly $0.09 per watt set the price. The power comes from policy plus a shortage, not from the product.
Demand driver
India's solar build-out and the policy push to source cells and modules domestically. More capacity installed, and a rising domestic-content share of it, means more demand for Indian-made cells. (Structural in direction but rent-cyclical in margin: the volume runway is long, yet the extraordinary profit per watt rides a temporary cell shortage.)
TAM
Large and growing. India targets hundreds of gigawatts of solar, with domestic-content demand alone estimated at 15-45 GW of modules a year. Exact figures vary by source.
Penetration
Early on installed capacity relative to targets, which is the bull case, but module manufacturing is already over-built while cell capacity lags, which is why the premium exists and why it is temporary.
Value-chain seat
Upstream of the assemblers and downstream of polysilicon and wafers. Emmvee sits at the cell-plus-module step, the most valuable domestic link right now precisely because it is the scarcest, but it still buys wafers and polysilicon, and plans to integrate further into ingots and wafers.
Emmvee is a genuinely better business than a bare panel assembler, and the numbers show it: 34% operating margin, 51% return on equity, a clean balance sheet after the IPO. The reason is its captive cell capacity, which lets it earn in the protected domestic-content segment that rivals cannot reach. But the honest framing is that this is a shortage rent, not a durable moat. Panels are a commodity, the premium is written by policy and scarcity, and the entire industry, Emmvee included with its new 6 GW plant, is spending heavily to build the cell capacity that ends the shortage. Emmvee is a good operator catching an unusually profitable moment in a business whose long-run economics are far thinner. The cash flows below say the same thing in a different language.
03Valuation Snapshot
Price
₹325
Market Cap
₹22,515 cr
52W High / Low
₹372 / ₹172
Stock P/E
17.7
computed price/EPS ≈ 17.1; cheapest of the listed integrated makers
P/B
6.1
book inflated by fast recent profit; ROE 51%
EPS (TTM)
₹18.98
Book Value
₹53.4
Dividend Yield
0.00%
reinvesting all of it into capacity
04Financial Performance (5Y, in Crores)
FY22
₹555net ₹13 · 2.3%
FY23
₹618net ₹9 · 1.5%
FY24
₹952net ₹29 · 3%
FY25
₹2,336net ₹369 · 15.8%
FY26
₹5,050net ₹1,082 · 21.4%
RevenueNet profit₹ crore · % = PAT margin
05Key Ratios
ROE
51.1%
ROCE
44.8%
at a peak-margin moment
Operating margin
~34%
cyclical peak, driven by the domestic-cell premium
D/E
0.10
near debt-free after IPO; interest cover ~11x
Cash conversion (FY26)
23%
OCF / profit; 5Y average ~82%
Inventory days
225
up from 197; working-capital build
06Cash Flow Forensics (in Crores)
FY24
OCF₹234FCF₹-440
FY25
OCF₹614FCF₹-375
FY26
OCF₹200FCF₹-440
This is the part the headline margin hides, and it deserves a clear eye. FY26 profit was ₹1,082 crore, but operating cash was only ₹200 crore, so just 23% of profit turned into cash that year, against a healthier five-year average near 82%. The money went into the business: inventory days rose to 225 and working-capital days swung from about minus 38 to plus 88 as the company scaled fast, and on top of that it is spending heavily on new plant, so free cash flow has been negative for three straight years (about minus ₹440 crore, minus ₹375 crore and minus ₹440 crore). None of this is a fraud pattern. The promoter holding is flat at 80%, the five-year cash conversion is decent, and the IPO fresh issue of about ₹2,144 crore did what it promised, cutting borrowings from roughly ₹2,065 crore to ₹360 crore. But it does mean the profit you see is not yet cash in hand. This is not cash burn because the business does not work. It is a business consuming cash faster than reported profit suggests, because growth demands inventory, receivables and factories. Whether that cash comes back as the expansion matures is the thing to watch, alongside the margin.
07Growth
Sales CAGR (5Y)
64%
Sales CAGR (3Y)
101%
off a small, cyclical base
Profit CAGR (5Y)
158%
not repeatable at this rate
Profit growth (TTM)
141%
still strong, driven by margin
Cash conversion (FY26)
23%
profit not yet turning to cash
08Management
Emmvee is founded and run by D.V. Manjunatha, who started the group in 1992 in solar water heaters and moved into solar panels in 2007; the family holds about 80% of the listed company, flat since the November 2025 listing, so there is no self-dilution. Nothing in the disclosures so far is an obvious governance red flag: the IPO used fresh money to repay debt rather than to cash out the promoter, and there is no visible pledging or unusual related-party pattern in what is disclosed so far. The harder question is not governance but capital allocation, and it is unproven. Can Emmvee earn an attractive return on the ₹5,500 crore, 6 GW expansion before the cell premium that makes today's returns look spectacular normalises? Every past capacity and technology call, the early bet on cells and the full shift to TOPCon, has landed well so far, but each was made into a widening shortage. This next one is being made into a shortage that is closing, which is a harder call, and it is the one to judge management on.
Captive cell capacity (2.94 GW) in a market short of domestic cells
Full TOPCon module capacity of 10.3 GW across five clustered plants
Eligibility for domestic-content tenders that pure assemblers cannot serve
A near debt-free balance sheet to fund the next expansion
Narrow is the honest reading. The edge is real, making your own cells when Indian cells are scarce unlocks the high-priced domestic-content market and is hard to copy quickly, but it is a moat made of policy and scarcity, not of brand, network or switching costs. It is a barrier against assemblers, not against the one thing that actually threatens it, the arrival of more domestic cell capacity, which is the flank the whole industry is racing to build. What matters is how long it lasts, not how high it looks today.
11The Story So Far
Emmvee spent most of its life as a mid-sized solar panel maker with ordinary economics: revenue around ₹550-950 crore and thin single-digit net margins through FY24. Then two things changed together. India's domestic-content rules tightened, rewarding panels built from Indian cells, and India turned out to be short of those cells. Emmvee had invested early in cell capacity, so it walked straight into the protected, high-priced segment while assemblers were left in the commoditised one. Revenue jumped to ₹2,336 crore in FY25 and ₹5,050 crore in FY26, net profit went from ₹29 crore to ₹1,082 crore, and the operating margin climbed to 34%. The November 2025 IPO raised about ₹2,144 crore of fresh capital, most of which repaid debt and left the balance sheet clean. The stock listed flat and has since risen to about ₹325, yet at roughly 17 times earnings it remains the cheapest of the listed integrated makers, which is the market's way of saying it does not expect a 34% margin to last.
12Risks
Margin reversion. The 34% margin rests on a domestic-cell shortage and a policy premium; as the industry's cell capacity, Emmvee's own included, comes online, the premium and the margin likely compress. High.
Cash conversion. FY26 turned only 23% of profit into operating cash, and free cash flow has been negative for three years as capex and working capital absorb money; reported profit is not yet cash. Medium to High.
Policy dependence. The domestic-content rules that create the premium are government policy and can be changed, relaxed or challenged, which would hit the high-margin segment directly. Medium to High.
Input-cost swings. Polysilicon and silver-paste costs (the latter about 8-9% of module cost) are volatile and can move the margin either way, independent of demand. Medium.
Execution and cyclicality. The ₹5,500 crore, 6 GW expansion must ramp on time into a market that could be softer on price by the time it lands, and solar manufacturing is a cyclical, capital-heavy business. Medium.
13What the Headline Numbers Hide
✓ clean! caution✕ red flag– n/a
✓
Promoter holding steady
Family holds 80.03%, flat since listing; no self-dilution
✓
IPO proceeds use
Fresh issue of ~₹2,144 crore mainly repaid debt (borrowings ₹2,065 cr to ₹360 cr), as promised
✓
Debt and leverage
Near debt-free post-IPO, D/E 0.10, interest cover ~11x
!
Cash conversion
FY26 OCF only 23% of profit; FCF negative three years running as working capital and capex build
!
Margin durability
34% margin driven by a domestic-cell shortage and policy premium, not proven structural
!
Base-year growth
Profit up from ₹29 cr (FY24) to ₹1,082 cr; explosive off a small, cyclical base
Sector checklist
✓
Captive cell capacity
2.94 GW of own cells feeding 10.3 GW modules: the edge in a cell-short market
✓
Order pipeline
Booked order pipeline of ~9.4 GW; visibility is good, pricing is the variable
!
Margin stability
~34% is far above normal panel economics; a shortage-and-policy premium likely to compress
!
Working capital / cash
Inventory 225 days, WC days swung to +88, FCF negative; cash lags profit
!
Import competition
Chinese TOPCon panels at ~$0.09/W undercut non-DCR pricing; premium holds only while rules and shortage do
15Mental-Model Lenses
The cell, not the panel
The clean way to see Emmvee is to separate the panel from the cell inside it. The panel is a commodity: glass, wiring, assembly, made cheaply by hundreds of firms and by China most cheaply of all. The cell is the hard, scarce part, and Emmvee makes its own. Most of the extraordinary margin comes from that one fact meeting one condition: India is short of domestic cells and its rules reward using them. So volume is not the question here. Unit economics are. Emmvee's order book can keep growing for years while the margin on each watt quietly falls, and a swelling order book is not proof the thesis is intact. Your return depends far less on how many panels Emmvee ships and far more on how long India stays short of cells, a shortage the whole industry is racing to end.
A cheap price on a peak margin
A 17-times-earnings multiple on a company growing this fast, earning 51% on equity, looks like a gift, and the market is handing it to you cheaper than Premier Energies at over 30. Read that discount as a warning, not a bargain. The number the multiple sits on is a 34% margin, and that margin is the shortage rent, not the panel. The balance sheet is clean and the growth is real; the fragile thing is the margin. If the shortage fades and the margin comes down, the low multiple was low for a reason. If the shortage holds, the stock was cheap. Which of those happens is not something the price can tell you.
Profit now, cash later
The one number that keeps the story honest is cash conversion: FY26 turned just 23% of a ₹1,082 crore profit into operating cash, and free cash flow has been negative for three years. This is not a fraud flag, the promoter stake is flat and the five-year conversion is decent, but it is a reminder that a fast-growing, capex-heavy manufacturer with a swelling working-capital cycle reports profit well before it collects cash. The reassuring version is that the cash arrives as the expansion matures and working capital settles. The worrying version is that the margin normalises before the cash ever shows up. Watch the conversion ratio quarter by quarter; it will tell you which version is happening long before the margin debate is settled.
16Outlook: What Happens Next?
The forward question is not whether Emmvee grows, the order book and new capacity make near-term growth likely, but what margin and how much cash that growth carries. Here is what has already happened, and the open question to watch in each area.
01
The margin
Q1 FY27 operating margin hit a record 35.2%, with the DCR segment about half of revenue at ~₹8.5-9 per watt.
Management guides a 30-35% EBITDA margin band and FY27 EBITDA of ₹2,200-2,400 crore.
What to watchWhether the DCR premium and the margin band hold as domestic cell capacity floods in across the industry, or start compressing toward normalised 20-24% economics.
02
The cash
FY26 operating cash was only ₹200 crore against ₹1,082 crore of profit, a 23% conversion.
Working-capital days swung from about minus 38 to plus 88 and inventory reached 225 days as the business scaled.
What to watchWhether cash conversion recovers toward the historical ~80% as the expansion matures, or the working-capital build persists and free cash flow stays negative.
03
The policy
Domestic-content rules already reward Indian cells, and from June 2026 an approved-list requirement for cells tightens the field further.
Chinese TOPCon panels sell around $0.09 per watt, far below Indian domestic-content prices.
What to watchWhether the domestic-content regime stays firm, since the premium that drives the whole margin is a policy choice, not a market outcome.
Engines loaded, not yet in the P&L
Capacity already won or acquired, but not yet showing up in reported earnings.
6 GW integrated cell-and-module plantFY27-28
A new ₹5,500 crore facility that lifts capacity toward 16.3 GW of modules and 8.94 GW of cells by FY28, deepening the captive-cell edge.
Under construction: the module line is expected around December 2026 and the cell line around March 2027, so it contributes little to current earnings.
Ingot and wafer integrationBeyond FY28
Planned upstream expansion into ingots and wafers (about 9 GW), which would push Emmvee further up the value chain and cut reliance on imported wafers.
Still at the planning stage, with no capacity or earnings yet; it is an intention, not a booked engine.
The next several quarters of margin prints and, just as important, cash-conversion prints should tell you which way this resolves.
17Summary
Emmvee is a genuinely better solar business than a bare panel assembler, and the numbers show it: a 34% operating margin, 51% return on equity, and a clean balance sheet after the IPO. It earns this by owning captive cell capacity, which lets it access the protected domestic-content market that rivals cannot reach. At about 17 times earnings it is modestly valued compared to peers, which is the market saying it doubts the 34% margin lasts. Two things keep the numbers in perspective. That margin is a shortage rent written by policy, and the whole industry, Emmvee included, is spending to build the cell capacity that ends the shortage. And the profit is not yet cash: FY26 turned only 23% of it into operating cash while free cash flow stayed negative. So the question is not whether the numbers look good today, they look excellent, but how much of the 34% margin survives once the shortage does not, and whether the cash follows the profit. This is not a buy or sell call. Do your own work and consult a SEBI-registered adviser.